nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Hypothyroidism—Sorafenib—liver cancer	0.0641	0.0641	CcSEcCtD
Ethionamide—Neurotoxicity—Epirubicin—liver cancer	0.0392	0.0392	CcSEcCtD
Ethionamide—Gynaecomastia—Sorafenib—liver cancer	0.0368	0.0368	CcSEcCtD
Ethionamide—Neurotoxicity—Doxorubicin—liver cancer	0.0363	0.0363	CcSEcCtD
Ethionamide—Optic neuritis—Epirubicin—liver cancer	0.0247	0.0247	CcSEcCtD
Ethionamide—Erectile dysfunction—Sorafenib—liver cancer	0.0238	0.0238	CcSEcCtD
Ethionamide—Weight decreased—Sorafenib—liver cancer	0.0234	0.0234	CcSEcCtD
Ethionamide—Optic neuritis—Doxorubicin—liver cancer	0.0229	0.0229	CcSEcCtD
Ethionamide—Neuropathy peripheral—Sorafenib—liver cancer	0.0226	0.0226	CcSEcCtD
Ethionamide—Stomatitis—Sorafenib—liver cancer	0.0224	0.0224	CcSEcCtD
Ethionamide—Jaundice—Sorafenib—liver cancer	0.0224	0.0224	CcSEcCtD
Ethionamide—Neuritis—Epirubicin—liver cancer	0.0204	0.0204	CcSEcCtD
Ethionamide—Neuritis—Doxorubicin—liver cancer	0.0189	0.0189	CcSEcCtD
Ethionamide—Dysgeusia—Sorafenib—liver cancer	0.0176	0.0176	CcSEcCtD
Ethionamide—Salivary hypersecretion—Epirubicin—liver cancer	0.0148	0.0148	CcSEcCtD
Ethionamide—Thrombocytopenia—Sorafenib—liver cancer	0.0144	0.0144	CcSEcCtD
Ethionamide—Anorexia—Sorafenib—liver cancer	0.014	0.014	CcSEcCtD
Ethionamide—Salivary hypersecretion—Doxorubicin—liver cancer	0.0137	0.0137	CcSEcCtD
Ethionamide—Dyspepsia—Sorafenib—liver cancer	0.0129	0.0129	CcSEcCtD
Ethionamide—Decreased appetite—Sorafenib—liver cancer	0.0128	0.0128	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.0127	0.0127	CcSEcCtD
Ethionamide—Photosensitivity—Epirubicin—liver cancer	0.0126	0.0126	CcSEcCtD
Ethionamide—Vascular purpura—Epirubicin—liver cancer	0.0123	0.0123	CcSEcCtD
Ethionamide—Gastrointestinal pain—Sorafenib—liver cancer	0.012	0.012	CcSEcCtD
Ethionamide—Photosensitivity—Doxorubicin—liver cancer	0.0116	0.0116	CcSEcCtD
Ethionamide—Abdominal pain—Sorafenib—liver cancer	0.0116	0.0116	CcSEcCtD
Ethionamide—Purpura—Epirubicin—liver cancer	0.0115	0.0115	CcSEcCtD
Ethionamide—Vascular purpura—Doxorubicin—liver cancer	0.0114	0.0114	CcSEcCtD
Ethionamide—Hypoglycaemia—Epirubicin—liver cancer	0.0113	0.0113	CcSEcCtD
Ethionamide—Diplopia—Epirubicin—liver cancer	0.011	0.011	CcSEcCtD
Ethionamide—Hypersensitivity—Sorafenib—liver cancer	0.0108	0.0108	CcSEcCtD
Ethionamide—Purpura—Doxorubicin—liver cancer	0.0106	0.0106	CcSEcCtD
Ethionamide—Hypoglycaemia—Doxorubicin—liver cancer	0.0105	0.0105	CcSEcCtD
Ethionamide—Diplopia—Doxorubicin—liver cancer	0.0102	0.0102	CcSEcCtD
Ethionamide—Orthostatic hypotension—Epirubicin—liver cancer	0.0101	0.0101	CcSEcCtD
Ethionamide—Diarrhoea—Sorafenib—liver cancer	0.01	0.01	CcSEcCtD
Ethionamide—Dizziness—Sorafenib—liver cancer	0.00971	0.00971	CcSEcCtD
Ethionamide—Vomiting—Sorafenib—liver cancer	0.00934	0.00934	CcSEcCtD
Ethionamide—Orthostatic hypotension—Doxorubicin—liver cancer	0.00933	0.00933	CcSEcCtD
Ethionamide—Rash—Sorafenib—liver cancer	0.00926	0.00926	CcSEcCtD
Ethionamide—Dermatitis—Sorafenib—liver cancer	0.00925	0.00925	CcSEcCtD
Ethionamide—Headache—Sorafenib—liver cancer	0.0092	0.0092	CcSEcCtD
Ethionamide—Nausea—Sorafenib—liver cancer	0.00872	0.00872	CcSEcCtD
Ethionamide—Photosensitivity reaction—Epirubicin—liver cancer	0.00871	0.00871	CcSEcCtD
Ethionamide—Weight decreased—Epirubicin—liver cancer	0.00863	0.00863	CcSEcCtD
Ethionamide—Drowsiness—Epirubicin—liver cancer	0.00851	0.00851	CcSEcCtD
Ethionamide—Neuropathy peripheral—Epirubicin—liver cancer	0.00834	0.00834	CcSEcCtD
Ethionamide—Stomatitis—Epirubicin—liver cancer	0.00829	0.00829	CcSEcCtD
Ethionamide—Jaundice—Epirubicin—liver cancer	0.00829	0.00829	CcSEcCtD
Ethionamide—Photosensitivity reaction—Doxorubicin—liver cancer	0.00806	0.00806	CcSEcCtD
Ethionamide—Weight decreased—Doxorubicin—liver cancer	0.00799	0.00799	CcSEcCtD
Ethionamide—Drowsiness—Doxorubicin—liver cancer	0.00787	0.00787	CcSEcCtD
Ethionamide—Neuropathy peripheral—Doxorubicin—liver cancer	0.00772	0.00772	CcSEcCtD
Ethionamide—Stomatitis—Doxorubicin—liver cancer	0.00767	0.00767	CcSEcCtD
Ethionamide—Jaundice—Doxorubicin—liver cancer	0.00767	0.00767	CcSEcCtD
Ethionamide—Hepatitis—Epirubicin—liver cancer	0.00764	0.00764	CcSEcCtD
Ethionamide—Hepatitis—Doxorubicin—liver cancer	0.00707	0.00707	CcSEcCtD
Ethionamide—Dysgeusia—Epirubicin—liver cancer	0.00651	0.00651	CcSEcCtD
Ethionamide—Vision blurred—Epirubicin—liver cancer	0.00627	0.00627	CcSEcCtD
Ethionamide—Agitation—Epirubicin—liver cancer	0.00611	0.00611	CcSEcCtD
Ethionamide—Dysgeusia—Doxorubicin—liver cancer	0.00603	0.00603	CcSEcCtD
Ethionamide—Vision blurred—Doxorubicin—liver cancer	0.0058	0.0058	CcSEcCtD
Ethionamide—Agitation—Doxorubicin—liver cancer	0.00565	0.00565	CcSEcCtD
Ethionamide—Thrombocytopenia—Epirubicin—liver cancer	0.00531	0.00531	CcSEcCtD
Ethionamide—Anorexia—Epirubicin—liver cancer	0.00517	0.00517	CcSEcCtD
Ethionamide—Thrombocytopenia—Doxorubicin—liver cancer	0.00492	0.00492	CcSEcCtD
Ethionamide—Somnolence—Epirubicin—liver cancer	0.00482	0.00482	CcSEcCtD
Ethionamide—Anorexia—Doxorubicin—liver cancer	0.00479	0.00479	CcSEcCtD
Ethionamide—Dyspepsia—Epirubicin—liver cancer	0.00478	0.00478	CcSEcCtD
Ethionamide—Decreased appetite—Epirubicin—liver cancer	0.00472	0.00472	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.00469	0.00469	CcSEcCtD
Ethionamide—Somnolence—Doxorubicin—liver cancer	0.00446	0.00446	CcSEcCtD
Ethionamide—Gastrointestinal pain—Epirubicin—liver cancer	0.00444	0.00444	CcSEcCtD
Ethionamide—Dyspepsia—Doxorubicin—liver cancer	0.00442	0.00442	CcSEcCtD
Ethionamide—Decreased appetite—Doxorubicin—liver cancer	0.00437	0.00437	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00434	0.00434	CcSEcCtD
Ethionamide—Abdominal pain—Epirubicin—liver cancer	0.00429	0.00429	CcSEcCtD
Ethionamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.00411	0.00411	CcSEcCtD
Ethionamide—Hypersensitivity—Epirubicin—liver cancer	0.004	0.004	CcSEcCtD
Ethionamide—Abdominal pain—Doxorubicin—liver cancer	0.00397	0.00397	CcSEcCtD
Ethionamide—Diarrhoea—Epirubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Ethionamide—Hypersensitivity—Doxorubicin—liver cancer	0.0037	0.0037	CcSEcCtD
Ethionamide—Dizziness—Epirubicin—liver cancer	0.00359	0.00359	CcSEcCtD
Ethionamide—Vomiting—Epirubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Ethionamide—Diarrhoea—Doxorubicin—liver cancer	0.00344	0.00344	CcSEcCtD
Ethionamide—Rash—Epirubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Ethionamide—Dermatitis—Epirubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Ethionamide—Headache—Epirubicin—liver cancer	0.0034	0.0034	CcSEcCtD
Ethionamide—Dizziness—Doxorubicin—liver cancer	0.00332	0.00332	CcSEcCtD
Ethionamide—Nausea—Epirubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Ethionamide—Vomiting—Doxorubicin—liver cancer	0.00319	0.00319	CcSEcCtD
Ethionamide—Rash—Doxorubicin—liver cancer	0.00317	0.00317	CcSEcCtD
Ethionamide—Dermatitis—Doxorubicin—liver cancer	0.00316	0.00316	CcSEcCtD
Ethionamide—Headache—Doxorubicin—liver cancer	0.00315	0.00315	CcSEcCtD
Ethionamide—Nausea—Doxorubicin—liver cancer	0.00298	0.00298	CcSEcCtD
